BIONDVAX PHARMACEUTICALS-ADR (BVXV) Stock Price, Quote, News and Overview

What is the stock price of BIONDVAX PHARMACEUTICALS-ADR today?

The current stock price of BVXV is 1.36 USD. The price increased by 3.82% in the last trading session.

What is the ticker symbol for BIONDVAX PHARMACEUTICALS-ADR stock?

The exchange symbol of BIONDVAX PHARMACEUTICALS-ADR is BVXV and it is listed on the Nasdaq exchange.

On which exchange is BVXV stock listed?

BVXV stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for BIONDVAX PHARMACEUTICALS-ADR stock?

7 analysts have analysed BVXV and the average price target is 39.78 USD. This implies a price increase of 2825% is expected in the next year compared to the current price of 1.36. Check the BIONDVAX PHARMACEUTICALS-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is BIONDVAX PHARMACEUTICALS-ADR worth?

BIONDVAX PHARMACEUTICALS-ADR (BVXV) has a market capitalization of 4.97M USD. This makes BVXV a Nano Cap stock.

How many employees does BIONDVAX PHARMACEUTICALS-ADR have?

BIONDVAX PHARMACEUTICALS-ADR (BVXV) currently has 33 employees.

What are the support and resistance levels for BIONDVAX PHARMACEUTICALS-ADR (BVXV) stock?

BIONDVAX PHARMACEUTICALS-ADR (BVXV) has a resistance level at 1.37. Check the full technical report for a detailed analysis of BVXV support and resistance levels.

Should I buy BIONDVAX PHARMACEUTICALS-ADR (BVXV) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of BVXV, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of BVXV, evaluating the profitability, health, valuation and growth aspects
• BIONDVAX PHARMACEUTICALS-ADR (BVXV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• BIONDVAX PHARMACEUTICALS-ADR (BVXV) Sales and EPS estimates to see what analysts future expectations are.
• BIONDVAX PHARMACEUTICALS-ADR (BVXV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• BIONDVAX PHARMACEUTICALS-ADR (BVXV) Insider and Institutional Ownership to learn about the owners and their transactions.
• BIONDVAX PHARMACEUTICALS-ADR (BVXV) Stock Chart to make your own analysis
• BIONDVAX PHARMACEUTICALS-ADR (BVXV) Latest news and press-releases to stay up to date.

Does BIONDVAX PHARMACEUTICALS-ADR (BVXV) stock pay dividends?

BVXV does not pay a dividend.

What is the Price/Earnings (PE) ratio of BIONDVAX PHARMACEUTICALS-ADR (BVXV)?

BIONDVAX PHARMACEUTICALS-ADR (BVXV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.86).

ChartMill assigns a fundamental rating of 1 / 10 to BVXV. Both the profitability and financial health of BVXV have multiple concerns.

Over the last trailing twelve months BVXV reported a non-GAAP Earnings per Share(EPS) of -6.86. The EPS decreased by -93.48% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to BVXV. The Buy consensus is the average rating of analysts ratings from 7 analysts.